Airtek (salmeterol, fluticasone propionate) aerosolum for inhalation 25 mcg/125 mcg/dose 120 doses

Description

Airtek Aerosolum for inhalation 25 mcg/125 mcg/dose:

The drug is intended for the treatment of bronchial asthma in patients who are shown to have combined therapy with long-acting β2-adrenomimetics and inhaled corticosteroids, namely:

• in case of insufficient control of the disease on the background of constant monotherapy with inhaled corticosteroids with periodic application of short-acting β2-adrenomimetics;
• in the case of adequate control of the disease on the background of therapy with inhaled corticosteroids and β2-adrenomimetics long-acting.